AquaBounty Technologies, Inc. develops and markets products to enhance productivity in land-based aquaculture. More Details
Flawless balance sheet with limited growth.
Share Price & News
How has AquaBounty Technologies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AQB's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: AQB exceeded the US Biotechs industry which returned 25% over the past year.
Return vs Market: AQB exceeded the US Market which returned 12% over the past year.
Price Volatility Vs. Market
How volatile is AquaBounty Technologies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StWho Has Been Buying AquaBounty Technologies, Inc. (NASDAQ:AQB) Shares?
2 months ago | Simply Wall StWhat Percentage Of AquaBounty Technologies, Inc. (NASDAQ:AQB) Shares Do Insiders Own?
3 months ago | Simply Wall StHave Insiders Been Buying AquaBounty Technologies, Inc. (NASDAQ:AQB) Shares?
Is AquaBounty Technologies undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate AQB's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate AQB's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: AQB is unprofitable, so we can't compare its PE Ratio to the US Biotechs industry average.
PE vs Market: AQB is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate AQB's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: AQB is overvalued based on its PB Ratio (3.8x) compared to the US Biotechs industry average (3.3x).
How is AquaBounty Technologies forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AQB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AQB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AQB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AQB's revenue (82.8% per year) is forecast to grow faster than the US market (10% per year).
High Growth Revenue: AQB's revenue (82.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AQB's Return on Equity is forecast to be high in 3 years time
How has AquaBounty Technologies performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AQB is currently unprofitable.
Growing Profit Margin: AQB is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: AQB is unprofitable, and losses have increased over the past 5 years at a rate of 15.8% per year.
Accelerating Growth: Unable to compare AQB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AQB is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-12.8%).
Return on Equity
High ROE: AQB has a negative Return on Equity (-41.12%), as it is currently unprofitable.
How is AquaBounty Technologies's financial position?
Financial Position Analysis
Short Term Liabilities: AQB's short term assets ($13.3M) exceed its short term liabilities ($2.0M).
Long Term Liabilities: AQB's short term assets ($13.3M) exceed its long term liabilities ($4.7M).
Debt to Equity History and Analysis
Debt Level: AQB's debt to equity ratio (14.4%) is considered satisfactory.
Reducing Debt: AQB's debt to equity ratio has reduced from 73.5% to 14.4% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AQB has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: AQB is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.
What is AquaBounty Technologies's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AQB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AQB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AQB's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AQB's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AQB's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Sylvia Wulf (62 yo)
Ms. Sylvia A. Wulf has been Chief Executive Officer, President and Executive Director of AquaBounty Technologies, Inc. since January 1, 2019. Ms. Wulf served as Senior Vice President and President of the M ...
CEO Compensation Analysis
Compensation vs Market: Sylvia's total compensation ($USD974.00K) is about average for companies of similar size in the US market ($USD1.36M).
Compensation vs Earnings: Insufficient data to compare Sylvia's compensation with company performance.
|CEO, President & Executive Director||1.75yrs||US$974.00k||0.60% |
|CFO & Treasurer||13yrs||US$314.91k||0.16% |
|Chief Operating Officer of AquaBounty Farms||6.58yrs||US$282.27k||0.062% |
|Chief Technology Officer||1.17yrs||no data||no data|
|General Counsel & Corporate Secretary||0.83yr||no data||0.067% |
|Director of Communications||no data||no data||no data|
|Chief Commercial Officer||1.25yrs||no data||no data|
|Financial Advisor||no data||no data||no data|
Experienced Management: AQB's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
|CEO, President & Executive Director||1.75yrs||US$974.00k||0.60% |
|Independent Non-Executive Director||14.75yrs||US$63.69k||0.18% |
|Independent Chairman of the Board||14.42yrs||US$92.24k||0.17% |
|Non-Executive Director||0.42yr||no data||0.0024% |
|Non-Executive Director||7yrs||no data||0.0053% |
|Independent Non-Executive Director||6.42yrs||US$68.69k||0.034% |
|Independent Non-Executive Director||7.58yrs||US$48.69k||0.073% |
|Non-Executive Director||0.42yr||no data||0.0048% |
Experienced Board: AQB's board of directors are considered experienced (6.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: AQB insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 107.9%.
AquaBounty Technologies, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: AquaBounty Technologies, Inc.
- Ticker: AQB
- Exchange: NasdaqCM
- Founded: 1991
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$170.684m
- Shares outstanding: 44.92m
- Website: https://www.aquabounty.com
Number of Employees
- AquaBounty Technologies, Inc.
- 2 Mill and Main Place
- Suite 395
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|AQB||NasdaqCM (Nasdaq Capital Market)||Yes||Common Stock||US||USD||Nov 2014|
|W8NB||BST (Boerse-Stuttgart)||Yes||Common Stock||DE||EUR||Nov 2014|
AquaBounty Technologies, Inc. develops and markets products to enhance productivity in land-based aquaculture. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption. The comp ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/31 00:25|
|End of Day Share Price||2020/10/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.